Importantly, the downregulation of angiogenic and matrix-degrading genes such as VEGF, MMP-2, MMP-9, HMGB1, and NF-κB p65 further supports its role in mitigating ECM destabilization and inflammatory amplification—hallmark events in aneurysm pathogenesis. The gene discussed is MMP2; the disease is aneurysm.